PLASBUMIN

This brand name is authorized in Canada, Cyprus, Spain, Hong Kong, Singapore, Turkey, United States

Active ingredients

The drug PLASBUMIN contains one active pharmaceutical ingredient (API):

1 Albumin UNII ZIF514RVZR - ALBUMIN HUMAN

Human albumin accounts quantitatively for more than half of the total protein in the plasma and represents about 10% of the protein synthesis activity of the liver. The most important physiological functions of albumin results from its contribution to oncotic pressure of the blood and transport function. Albumin stabilises circulating blood volume and is a carrier of hormones, enzymes, medicinal products and toxins. Read about Albumin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B05AA01	Albumin	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions
Discover more medicines within B05AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02189100
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61499
Country: HK	Department of Health Drug Office	Identifier(s): 06008
Country: SG	Health Sciences Authority	Identifier(s): 01972P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699769980269, 8699769980276, 8699769980283, 8699769980290
Country: US	FDA, National Drug Code	Identifier(s): 13533-690, 13533-691, 13533-692